Reliability of Large Language Model Generated Clinical Reasoning in Assisted Reproductive Technology: Blinded Comparative Evaluation Study.
Dou Liu, Ying Long, Sophia Zuoqiu, Di Liu, Kang Li, Yiting Lin, Hanyi Liu, Rong Yin, Tian Tang
Abstract
Open AccessBACKGROUND: High-quality clinical chains-of-thought (CoTs) are essential for explainable medical artificial intelligence (AI); yet, their development is limited by data scarcity. Large language models can generate medical CoTs, but their clinical reliability is unclear. OBJECTIVE: We evaluated the clinical reliability of large language model-generated CoTs in reproductive medicine and examined prompting strategies to improve their quality. METHODS: In a blinded comparative study at a clinical center, senior clinicians in assisted reproductive technology evaluated CoTs generated via 3 distinct strategies: zero-shot, random few-shot (using random shallow examples), and selective few-shot (using diverse, high-quality examples). Expert ratings were then compared with evaluations from a state-of-the-art AI model (GPT-4o). RESULTS: The selective few-shot strategy significantly outperformed other strategies across logical clarity, use of key information, and clinical accuracy (P<.001). Critically, the random few-shot strategy offered no significant improvement over the zero-shot baseline, demonstrating that low-quality examples are as ineffective as no examples. The success of the selective strategy is attributed to 2 preliminary frameworks: "gold-standard depth" and "representative diversity." Notably, the AI evaluator failed to discern these critical performance differences. Thus, clinical reliability depends on strategic prompt design rather than simply adding examples. CONCLUSIONS: We propose a "dual principles" preliminary framework for generating trustworthy CoTs at scale in assisted reproductive technology. This work is a preliminary step toward addressing the data bottleneck in reproductive medicine. It also underscores the essential role of human expertise in evaluating generated clinical data.